Rija Amir
Physician Assistant · New Orleans, LANPI 1639743834
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.7% of the total across 341 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 23 manufacturers reported payments, led by Amgen at 24.3% of the total. Reporting peaked in 2023 at $2,202 and has fallen 86.5% since, to $296 in 2025. Among physician assistant clinicians in LA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 341 payments — averaging $20.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$2K
- UCB, Inc.$806
- Aurinia Pharma U.S., Inc.$736
- AbbVie$521
- Mallinckrodt Hospital Products Inc.$519
- AstraZeneca$428
- plus $2K from 17 others
What the payments were for
- Food & beverage$6,818100%
- Education$210%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 92 | $1,664 |
| UCB, Inc. | 29 | $806 |
| Aurinia Pharma U.S., Inc. | 36 | $736 |
| AbbVie | 30 | $521 |
| Mallinckrodt Hospital Products Inc. | 21 | $519 |
| AstraZeneca | 23 | $428 |
| GSK | 17 | $379 |
| Novartis | 18 | $333 |
| Organon | 24 | $253 |
| Johnson & Johnson | 10 | $224 |
| Pfizer | 8 | $212 |
| Radius Health, Inc. | 7 | $137 |
| Tersera Therapeutics LLC | 4 | $121 |
| Lilly USA, LLC | 6 | $108 |
| ANI Pharmaceuticals, Inc. | 3 | $85 |
| Octapharma USA, Inc. | 1 | $66 |
| E.r. Squibb & Sons, L.L.C. | 3 | $66 |
| Boehringer Ingelheim | 2 | $41 |
| Genentech USA, Inc. | 2 | $39 |
| Fresenius Kabi USA, LLC | 2 | $35 |
| Sanofi | 1 | $25 |
| Actelion Pharmaceuticals US, Inc. | 1 | $21 |
| Sandoz | 1 | $21 |
How this compares
$6,839 in reported general payments places this provider in the 95th percentile of 1,246 physician assistant providers in Louisiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 21 | $147,370 |
| Enbrel SureclickEtanercept | 17 | $139,738 |
| Humira PenAdalimumab | 12 | $110,090 |
| Xeljanz XrTofacitinib Citrate | 15 | $86,715 |
| Cosentyx Sensoready (2 Pens)Secukinumab | 12 | $84,327 |
| Hydroxychloroquine Sulfate | 506 | $13,728 |
| MethotrexateMethotrexate Sodium | 241 | $4,069 |
| Celecoxib | 78 | $3,296 |
| Gabapentin | 231 | $3,250 |
| Leflunomide | 25 | $1,537 |
| Pregabalin | 44 | $1,071 |
| Sulfasalazine | 53 | $804 |
| Duloxetine Hcl | 45 | $791 |
| Azathioprine | 21 | $618 |
| Diclofenac Sodium | 33 | $600 |
Paid to pharmacies, not to this prescriber.
Other physician assistant in New Orleans
- Jefferson OberleNew Orleans$66K
- Jennifer ScheuermannNew Orleans$56K
- Elizabeth ClementNew Orleans$35K
- David GsellNew Orleans$26K
- Nakia BrooksNew Orleans$25K
- Sydney TsenNew Orleans$16K
- Stephanie EscheteNew Orleans$9K
- Emily EstopinalNew Orleans$6K
- Shelly EsnardBaton Rouge$141K
- Claire DarreJefferson$50K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.